367 related articles for article (PubMed ID: 35401558)
21. Allograft inflammatory factor 1 is a potential diagnostic, immunological, and prognostic biomarker in pan-cancer.
Liu X; Zhang D; Hu J; Xu S; Xu C; Shen Y
Aging (Albany NY); 2023 Apr; 15(7):2582-2609. PubMed ID: 37014322
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of protein disulfide-isomerase A3 isoforms, PDIA3 and PDIA3N, in human prostate cancer cell lines representing different stages of prostate cancer.
Diaz Cruz MA; Karlsson S; Szekeres F; Faresjö M; Lund D; Larsson D
Mol Biol Rep; 2021 Mar; 48(3):2429-2436. PubMed ID: 33761087
[TBL] [Abstract][Full Text] [Related]
23. ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas.
Li J; Zhang Y; Qu Z; Ding R; Yin X
Front Cell Infect Microbiol; 2022; 12():956801. PubMed ID: 35959373
[TBL] [Abstract][Full Text] [Related]
24. Protein disulfide isomerase A3 as novel biomarker for endometrial cancer.
Yu F; Liu X; Li M; Liu X; Wang X; Guo M
Front Oncol; 2023; 13():1247446. PubMed ID: 37909009
[TBL] [Abstract][Full Text] [Related]
25. Protein disulfide-isomerase A3 knockdown attenuates oxidized low-density lipoprotein-induced oxidative stress, inflammation and endothelial dysfunction in human umbilical vein endothelial cells by downregulating activating transcription factor 2.
Jia J; Wang Y; Huang R; Du F; Shen X; Yang Q; Li J
Bioengineered; 2022 Jan; 13(1):1436-1446. PubMed ID: 34983301
[TBL] [Abstract][Full Text] [Related]
26. Lung epithelial protein disulfide isomerase A3 (PDIA3) plays an important role in influenza infection, inflammation, and airway mechanics.
Chamberlain N; Korwin-Mihavics BR; Nakada EM; Bruno SR; Heppner DE; Chapman DG; Hoffman SM; van der Vliet A; Suratt BT; Dienz O; Alcorn JF; Anathy V
Redox Biol; 2019 Apr; 22():101129. PubMed ID: 30735910
[TBL] [Abstract][Full Text] [Related]
27. Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy.
Li K; Liu J; Yang X; Tu Z; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34762107
[TBL] [Abstract][Full Text] [Related]
28. Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy.
Tu Z; Li K; Ji Q; Huang Y; Lv S; Li J; Wu L; Huang K; Zhu X
BMC Cancer; 2023 Feb; 23(1):133. PubMed ID: 36759763
[TBL] [Abstract][Full Text] [Related]
29. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X
Front Immunol; 2023; 14():1071675. PubMed ID: 36761737
[TBL] [Abstract][Full Text] [Related]
30. Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors.
Zhu M; Wang X; Zhang Q; Xie C; Wang T; Shen K; Zhang L; Zhou X
Aging (Albany NY); 2024 Feb; 16(3):2563-2590. PubMed ID: 38315450
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of protein disulfide‑isomerase A3 expression inhibits cell proliferation and induces apoptosis through STAT3 signaling in hepatocellular carcinoma.
Kondo R; Ishino K; Wada R; Takata H; Peng WX; Kudo M; Kure S; Kaneya Y; Taniai N; Yoshida H; Naito Z
Int J Oncol; 2019 Apr; 54(4):1409-1421. PubMed ID: 30720090
[TBL] [Abstract][Full Text] [Related]
32. Protein Disulfide Isomerase A3 (PDIA3): A Pharmacological Target in Glioblastoma?
Paglia G; Minacori M; Meschiari G; Fiorini S; Chichiarelli S; Eufemi M; Altieri F
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686085
[TBL] [Abstract][Full Text] [Related]
33. Silencing of ER-resident oxidoreductase PDIA3 inhibits malignant biological behaviors of multidrug-resistant gastric cancer.
Song D; Guo M; Wu K; Hao J; Nie Y; Fan D
Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1216-1226. PubMed ID: 34363072
[TBL] [Abstract][Full Text] [Related]
34. Pan-cancer analysis of the disulfidptosis-related gene
Zong Y; Zhu A; Liu P; Fu P; Li Y; Chen S; Gao X
Heliyon; 2024 Jun; 10(11):e31875. PubMed ID: 38845861
[TBL] [Abstract][Full Text] [Related]
35. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
36. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
37. Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas.
Hu Q; Huang K; Tao C; Zhu X
J Cell Mol Med; 2020 May; 24(10):5888-5900. PubMed ID: 32301283
[TBL] [Abstract][Full Text] [Related]
38. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
Front Immunol; 2022; 13():849592. PubMed ID: 35444654
[TBL] [Abstract][Full Text] [Related]
39. Impairment of cell adhesion and migration by inhibition of protein disulphide isomerases in three breast cancer cell lines.
Young HS; McGowan LM; Jepson KA; Adams JC
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33095243
[TBL] [Abstract][Full Text] [Related]
40. Protein disulfide isomerase-P5, down-regulated in the final stage of boar epididymal sperm maturation, catalyzes disulfide formation to inhibit protein function in oxidative refolding of reduced denatured lysozyme.
Akama K; Horikoshi T; Sugiyama A; Nakahata S; Akitsu A; Niwa N; Intoh A; Kakui Y; Sugaya M; Takei K; Imaizumi N; Sato T; Matsumoto R; Iwahashi H; Kashiwabara S; Baba T; Nakamura M; Toda T
Biochim Biophys Acta; 2010 Jun; 1804(6):1272-84. PubMed ID: 20152940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
